|
JPH0517363A
(ja)
|
1991-07-11 |
1993-01-26 |
Yakult Honsha Co Ltd |
抗炎症剤及びそれを含有する化粧料
|
|
US5716615A
(en)
|
1992-02-10 |
1998-02-10 |
Renata Maria Anna Cavaliere Vesely |
Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
|
|
US5531989A
(en)
|
1994-10-28 |
1996-07-02 |
Metagenics, Inc. |
Immunoglobulin and fiber-containing composition for human gastrointestinal health
|
|
CN1066926C
(zh)
|
1996-04-08 |
2001-06-13 |
钟春燕 |
将椰子水发酵制作的食用纤维及其生产方法
|
|
US6461607B1
(en)
|
1998-08-24 |
2002-10-08 |
Ganeden Biotech, Inc. |
Probiotic, lactic acid-producing bacteria and uses thereof
|
|
CZ9900769A3
(cs)
|
1999-03-04 |
2000-10-11 |
Petr Ing. Drsc. Hušek |
Použití špičky s filtrem k vytvoření sloupce sorbentu s definovaným objemem v prostoru pod filtrem
|
|
US20020090416A1
(en)
|
1999-03-09 |
2002-07-11 |
Philip Connolly |
Method of enhancing absorption and utilization of protein
|
|
IT1307850B1
(it)
*
|
1999-03-15 |
2001-11-19 |
Italmed Di Galli Giovanna E Pa |
Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio
|
|
EP1145643A1
(en)
|
2000-04-10 |
2001-10-17 |
Phillip Connolly |
Improved milk protein concentrate
|
|
US20040170617A1
(en)
|
2000-06-05 |
2004-09-02 |
Finegold Sydney M. |
Method of treating diseases associated with abnormal gastrointestinal flora
|
|
RU2182008C1
(ru)
|
2000-10-20 |
2002-05-10 |
Самойленко Игорь Иннокентьевич |
Вводимая перорально, ректально или интравагинально композиция, содержащая живые бактерии
|
|
PE20030284A1
(es)
|
2001-07-26 |
2003-05-01 |
Alimentary Health Ltd |
Cepas de bifidobacterium
|
|
FI20020078A7
(fi)
*
|
2002-01-15 |
2003-07-16 |
Danisco |
Immuunijärjestelmän stimulointi polydextroosilla
|
|
US6881419B2
(en)
*
|
2002-04-09 |
2005-04-19 |
William E. Lovett |
Vitamin formulation for enhancing bone strength
|
|
CN1627948A
(zh)
|
2002-04-24 |
2005-06-15 |
麦迪卡博公司 |
治疗炎症性肠病的组合物和试剂盒
|
|
JP2005534315A
(ja)
|
2002-08-06 |
2005-11-17 |
ダニスコ エイ／エス |
食品および薬学的組成物中に細胞外多糖類を産生する乳酸桿菌の使用
|
|
AU2002951270A0
(en)
|
2002-09-06 |
2002-09-19 |
Vri Biomedical Ltd |
Probiotic Bacterium and Methods of Use
|
|
WO2005001109A2
(en)
|
2003-05-06 |
2005-01-06 |
Government Of The United States Of America As Represented By The Sercretary Of The Department Of Health And Human Services National Institutes Of Health |
Methods and compositions to detect microbes in fecal samples
|
|
US20100112088A1
(en)
*
|
2003-08-29 |
2010-05-06 |
Jay Pravda |
Materials and methods for treatment of disorders associated with oxidative stress
|
|
CA2557543A1
(en)
|
2004-02-27 |
2005-09-09 |
Stichting Laboratorium Voor Infectieziekten |
Method for detecting a microorganism in a fecal specimen
|
|
KR20060114370A
(ko)
|
2004-03-04 |
2006-11-06 |
이엘씨 매니지먼트 엘엘씨 |
락토바실러스(Ｌａｃｔｏｂａｃｉｌｌｕｓ) 추출물을이용한 피부 치료 방법
|
|
EP2280085A3
(en)
|
2004-11-01 |
2011-02-23 |
George Mason University |
Compositions and methods for diagnosing colon disorders
|
|
SG161234A1
(en)
*
|
2005-04-06 |
2010-05-27 |
Novartis Ag |
A method and composition for nutritionally improving glucose control and insulin action
|
|
FI20051319L
(fi)
|
2005-12-22 |
2007-06-23 |
Cyflo Oy |
Menetelmä eläimen ja/tai ihmisen ravitsemuksen ja hyvinvoinnin ja eläinten tuottavuuden seuraamiseksi ja kehittämiseksi
|
|
CN1840206A
(zh)
|
2006-01-19 |
2006-10-04 |
上海交通大学 |
人源菌群仔猪模型的构建及仔猪肠道中菌群分子检测方法
|
|
ES2426038T3
(es)
|
2006-02-21 |
2013-10-18 |
National University Corporation University Of Toyama |
Procedimiento rápido para identificar el microorganismo causante de una enfermedad infecciosa
|
|
EP1992645A4
(en)
|
2006-02-24 |
2011-03-09 |
Q P Corp |
NOVEL HYALURONIC ACID WITH LOW MOLECULAR WEIGHT AND / OR SALT THEREOF, AND COSMETIC PREPARATION, PHARMACEUTICAL COMPOSITION AND EACH FOOD COMPOSITION USING THE SAME
|
|
EP2012596A1
(en)
*
|
2006-05-03 |
2009-01-14 |
Anidral S.R.L. |
Symbiotic composition comprising non-digestible polysaccharides and bifidobacteria which metabolize them and its uses
|
|
WO2007140621A1
(en)
|
2006-06-09 |
2007-12-13 |
Nutravital Inc. |
Probiotic compositions and uses thereof
|
|
US20080069861A1
(en)
|
2006-09-19 |
2008-03-20 |
National Starch And Chemical Investment Holding Corporation |
Probiotic/Non-Probiotic Combinations
|
|
US20080081035A1
(en)
*
|
2006-10-03 |
2008-04-03 |
National Enzyme Company |
Therapeutic protease compositions
|
|
JP5285617B2
(ja)
|
2006-12-18 |
2013-09-11 |
アドバンスド バイオニュートリション コーポレーション |
生きたプロバイオティクスを含む乾燥食物製品
|
|
EP1972208A1
(en)
*
|
2007-03-16 |
2008-09-24 |
Kirin Holdings Kabushiki Kaisha |
Composition for improving intestinal microflora
|
|
BRPI0809454A2
(pt)
|
2007-03-27 |
2014-09-09 |
Procter & Gamble |
Métodos e kits para a administração de probióticos
|
|
EP2155167A2
(en)
|
2007-06-04 |
2010-02-24 |
Egalet A/S |
Controlled release pharmaceutical compositions for prolonged effect
|
|
RU2469558C2
(ru)
*
|
2007-07-06 |
2012-12-20 |
Н.В. Нютрисиа |
Применение пробиотиков и волокон при диарее
|
|
US8193155B2
(en)
|
2009-02-09 |
2012-06-05 |
Elc Management, Llc |
Method and compositions for treating skin
|
|
US20090098088A1
(en)
|
2007-10-10 |
2009-04-16 |
The Procter & Gamble Company |
Methods And Kits For The Treatment Of Diverticular Conditions
|
|
CN101240315A
(zh)
|
2008-02-21 |
2008-08-13 |
上海交通大学 |
检测药物防癌效果的非损伤性分子方法
|
|
AU2009243066A1
(en)
|
2008-05-01 |
2009-11-05 |
The Procter & Gamble Company |
Methods and kits for the treatment of inflammatory bowel disorder conditions
|
|
WO2010008272A1
(en)
|
2008-07-15 |
2010-01-21 |
N.V. Nutricia |
Treatment of gut motility disorders
|
|
JP2010161944A
(ja)
|
2009-01-13 |
2010-07-29 |
Syngen Biotech Co Ltd |
新型カゼイ菌の亜種（ｓｇ９６）及びこれを含有する菌抑制組成物及びその用途
|
|
PL2403510T3
(pl)
|
2009-03-05 |
2020-06-29 |
Probiotical S.P.A. |
Szczepy bakteryjne o wysokiej aktywności przeciwzapalnej
|
|
WO2010103132A1
(es)
|
2009-03-10 |
2010-09-16 |
Hero España, S.A. |
Aislamiento, identificación y caracterización de cepas con actividad probiótica a partir de heces de lactantes alimentados exclusivamente con leche materna
|
|
JP2013505289A
(ja)
|
2009-09-23 |
2013-02-14 |
トーマス・ジュリアス・ボロディ |
腸管感染症の治療法
|
|
WO2011060123A1
(en)
*
|
2009-11-12 |
2011-05-19 |
Nestec S.A. |
Nutritional composition for promoting gut microbiota balance and health
|
|
AU2010334993B2
(en)
*
|
2009-12-22 |
2015-07-09 |
Probi Ab |
Non-fermented compositions comprising a cereal based fraction and a probiotic and uses thereof
|
|
US8575130B2
(en)
|
2010-01-04 |
2013-11-05 |
Holy Stone Healthcare Co., Ltd. |
Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease
|
|
ITUD20100112A1
(it)
|
2010-06-09 |
2011-12-10 |
Farma Derma S R L |
Preparazione per uso vaginale e rettale e relativo procedimento di produzione
|
|
WO2012135499A1
(en)
|
2011-03-31 |
2012-10-04 |
Ganeden Biotech, Inc. |
Probiotic sports nutrition compositions
|
|
US20140072621A1
(en)
|
2011-05-09 |
2014-03-13 |
The Cleveland Clinic Foundation |
Composition and method to improve intestinal health
|
|
RU2748839C2
(ru)
|
2011-06-20 |
2021-05-31 |
Х.Дж. Хайнц Компани Брэндс Ллк |
Композиции, способы и наборы для стимулирования мукозальной иммунной системы
|
|
GB201219873D0
(en)
|
2012-11-05 |
2012-12-19 |
Multigerm Uk Entpr Ltd |
Diverticulitis treatment
|
|
CN102919922A
(zh)
|
2012-11-08 |
2013-02-13 |
黑龙江省轻工科学研究院 |
一种复合益生菌发酵蓝莓果汁粉的制备方法
|
|
KR20150134356A
(ko)
|
2013-03-05 |
2015-12-01 |
리엑스유니버시테이트 그로닝겐 |
염증을 억제하기 위한 페칼리 박테리움 프라우스니치이 htf-f (dsm 26943)의 용도
|
|
KR102250588B1
(ko)
|
2013-07-02 |
2021-05-12 |
오스트리아노바 싱가포르 피티이 리미티드 |
캡슐화 세포의 동결-건조 방법, 동결 건조된 캡슐화 세포, 동결 건조된 캡슐화 세포를 함유하는 조성물, 및 상기 세포 및 조성물의 용도
|
|
ITMI20131473A1
(it)
|
2013-09-06 |
2015-03-07 |
Sofar Spa |
Metodo per valutare gli effetti di una composizione comprendente microrganismi sul microbiota intestinale
|
|
ITMI20131467A1
(it)
|
2013-09-06 |
2015-03-07 |
Sofar Spa |
Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
|
|
MA39710A
(fr)
|
2014-04-23 |
2015-10-29 |
Sofar Spa |
Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
|
|
WO2015172191A1
(en)
|
2014-05-12 |
2015-11-19 |
Medlab Ip Pty Ltd |
Probiotic compositions and uses thereof for treatment of obesity-related disorders
|
|
ES2610994T3
(es)
|
2014-08-26 |
2017-05-04 |
Chr. Hansen A/S |
Bifidobacterium animalis subsp. lactis para el uso en la reducción del dolor abdominal en una mujer postmenopáusica
|
|
WO2017195182A1
(en)
|
2016-05-13 |
2017-11-16 |
Sofar S.P.A. |
Use of probiotics for improving protein absorption
|
|
MA45327A
(fr)
|
2016-05-13 |
2019-03-20 |
Sofar Spa |
Utilisation de probiotiques pour améliorer l'absorption des protéines
|
|
MA45288A
(fr)
|
2016-06-08 |
2019-04-17 |
Sofar Spa |
Nouvelle utilisation médicale de probiotiques
|
|
IT201600122724A1
(it)
|
2016-12-02 |
2018-06-02 |
Sofar Spa |
Exopolysaccharides and uses thereof
|
|
IT201600127498A1
(it)
|
2016-12-16 |
2018-06-16 |
Sofar Spa |
Probiotici per uso nella diverticolosi e malattia diverticolare
|
|
EP3554517B1
(en)
|
2016-12-16 |
2023-09-13 |
Compagnie Gervais Danone |
Probiotic composition comprising lactobacillus rhamnosus and lactobacillus paracasei strains
|
|
WO2019019961A1
(zh)
|
2017-07-26 |
2019-01-31 |
海思科医药集团股份有限公司 |
防治消化道和/或皮肤反应的菌群及其应用
|
|
IT201700101704A1
(it)
|
2017-09-12 |
2019-03-12 |
Sofar Spa |
Nuovo uso per trattamento delle infezioni da clostridium difficile
|
|
WO2019111189A1
(en)
|
2017-12-06 |
2019-06-13 |
Sofar S.P.A. |
Composition based on probiotics and uses thereof
|
|
CN108743851A
(zh)
|
2018-08-09 |
2018-11-06 |
深圳市博奥生物科技有限公司 |
一种复合益生菌粉的制备方法及复合益生菌粉
|
|
IT201900016805A1
(it)
|
2019-09-20 |
2021-03-20 |
Sofar Spa |
Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali
|
|
IT201900016865A1
(it)
|
2019-09-20 |
2021-03-20 |
Sofar Spa |
Composizioni a base di ceppi batterici e loro uso come antinfiammatori
|
|
IT201900016850A1
(it)
|
2019-09-20 |
2021-03-20 |
Sofar Spa |
Composizioni a base di ceppi batterici e estratti di bacche e loro uso come antinfiammatori
|
|
IT201900016811A1
(it)
|
2019-09-20 |
2021-03-20 |
Sofar Spa |
Ceppi batterici, loro composizioni e loro uso per il trattamento di disturbi gastrointestinali
|
|
IT201900020422A1
(it)
|
2019-11-05 |
2021-05-05 |
Sofar Spa |
Composizioni comprendenti ceppi di batteri per uso per aumentare la biodisponibilità degli amminoacidi derivanti da proteine
|
|
US11751597B2
(en)
|
2019-11-05 |
2023-09-12 |
Alfasigma S.P.A. |
Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
|